These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha. Zuckerman E; Keren D; Rozenbaum M; Toubi E; Slobodin G; Tamir A; Naschitz JE; Yeshurun D; Rosner I Clin Exp Rheumatol; 2000; 18(5):579-84. PubMed ID: 11072597 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus associated arthritis in absence of clinical, biochemical and histological evidence of liver disease--responding to interferon therapy. Akhtar AJ; Funnyé AS Med Sci Monit; 2005 Jul; 11(7):CS37-9. PubMed ID: 15990694 [TBL] [Abstract][Full Text] [Related]
4. Occurrence of hepatocellular carcinoma 13 years after successful antiviral treatment for HCV infection. Puoti C; Lanzetta G; Scotti E J Gastrointestin Liver Dis; 2016 Sep; 25(3):408-9. PubMed ID: 27689211 [No Abstract] [Full Text] [Related]
5. A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis. Shimada M; Yoshida S; Kornek M; Kim SJ; Schuppan D Liver Int; 2010 Nov; 30(10):1552-4. PubMed ID: 20557455 [No Abstract] [Full Text] [Related]
6. Catatonia associated with pegylated interferon-α 2b and ribavirin for hepatitis C. Quinn D; Kuchler E; Deming P; Arora S Psychosomatics; 2012; 53(4):400-1. PubMed ID: 22748752 [No Abstract] [Full Text] [Related]
7. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy. Tong MJ; Lai LP; Murakami-Mori K West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751 [No Abstract] [Full Text] [Related]
8. HCV infection in the setting of HIV: prevalence, disease, treatment. Laurence J AIDS Read; 2006 Mar; 16(3):115-6. PubMed ID: 16538952 [No Abstract] [Full Text] [Related]
9. Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C. Niewold TB; Gibofsky A Arthritis Rheum; 2006 Jul; 54(7):2335-7. PubMed ID: 16802375 [No Abstract] [Full Text] [Related]
10. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha and ribavirin. Misery L J Interferon Cytokine Res; 2002 Aug; 22(8):881-2. PubMed ID: 12396727 [TBL] [Abstract][Full Text] [Related]
11. Psoriatic arthritis and alpha-interferon. Olivieri I; Padula A; Ciancio G; La Civita L Scand J Rheumatol; 2001; 30(3):175. PubMed ID: 11469531 [No Abstract] [Full Text] [Related]
17. Interferon for hepatitis C patients with psychiatric disorders. Asnis GM; De La Garza R; Rego SA; Henderson MA; Reinus JF Am J Psychiatry; 2004 Dec; 161(12):2332; author reply 2332-4. PubMed ID: 15569920 [No Abstract] [Full Text] [Related]
18. New combination treatment for hepatitis C is more beneficial than standard therapy, study says. Levenson D Rep Med Guidel Outcomes Res; 2002 Oct; 13(20):5-6. PubMed ID: 12599388 [No Abstract] [Full Text] [Related]
19. Hepatitis C treatment, HAART and side effects. TreatmentUpdate; 2001; 13(7):7-8. PubMed ID: 11794865 [No Abstract] [Full Text] [Related]
20. Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature. Ahmad U; Li X; Sodeman T; Daboul I Am J Ther; 2013; 20(5):585-7. PubMed ID: 21317616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]